| Ofatumumab versus teriflunomide in multiple sclerosis SL Hauser, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, AH Cross, ... New England Journal of Medicine 383 (6), 546-557, 2020 | 524 | 2020 |
| Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis JWL Brown, A Coles, E Havrdova, G Izquierdo, A Prat, M Girard, ... JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 321 (2), 175-187, 2019 | 481 | 2019 |
| Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis T Chitnis, DL Arnold, B Banwell, W Brück, A Ghezzi, G Giovannoni, ... New England Journal of Medicine 379 (11), 1017-1027, 2018 | 327 | 2018 |
| Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients N Yozbatıran, F Baskurt, Z Baskurt, S Ozakbas, E Idiman Journal of the neurological sciences 246 (1-2), 117-122, 2006 | 255 | 2006 |
| Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ... Neurology 97 (19), e1870-e1885, 2021 | 227 | 2021 |
| Sexual dysfunction ın multiple sclerosis: gender differences DB Çelik, EÇ Poyraz, A Bingöl, E İdiman, S Özakbaş, D Kaya Journal of the Neurological Sciences 324 (1-2), 17-20, 2013 | 153 | 2013 |
| Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample E Idiman, F Uzunel, S Ozakbas, N Yozbatiran, M Oguz, B Callioglu, ... Journal of the neurological sciences 240 (1-2), 77-80, 2006 | 142 | 2006 |
| Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in … S Ozakbas, I Cagiran, B Ormeci, E Idiman Journal of the neurological sciences 218 (1-2), 3-7, 2004 | 133 | 2004 |
| Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features S Ozakbas, E Idiman, B Baklan, B Yulug Brain and Development 25 (4), 233-236, 2003 | 109 | 2003 |
| Nitric oxide as an activity marker in multiple sclerosis G Acar, F Idiman, E Idiman, G Kırkalı, H Çakmakçı, S Özakbaş Journal of neurology 250, 588-592, 2003 | 109 | 2003 |
| Social cognition in multiple sclerosis: a meta-analysis E Bora, S Özakbaş, D Velakoulis, M Walterfang Neuropsychology Review 26, 160-172, 2016 | 95 | 2016 |
| Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis T Kalincik, EK Havrdova, D Horakova, G Izquierdo, A Prat, M Girard, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 458-468, 2019 | 92 | 2019 |
| Risk of secondary progressive multiple sclerosis: a longitudinal study A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, ... Multiple Sclerosis Journal 26 (1), 79-90, 2020 | 84 | 2020 |
| The effects of Clinical Pilates training on walking, balance, fall risk, respiratory, and cognitive functions in persons with multiple sclerosis: A randomized controlled trial Z Abasıyanık, Ö Ertekin, T Kahraman, P Yigit, S Özakbaş Explore 16 (1), 12-20, 2020 | 67 | 2020 |
| Effect of video-based exergaming on arm and cognitive function in persons with multiple sclerosis: A randomized controlled trial AT Ozdogar, O Ertekin, T Kahraman, P Yigit, S Ozakbas Multiple sclerosis and related disorders 40, 101966, 2020 | 60 | 2020 |
| The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds E Idiman, S Ozakbas, Y Dogan, G Kosehasanogullari Journal of neuroimmunology 212 (1-2), 121-124, 2009 | 59 | 2009 |
| Natalizumab, fingolimod, and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis WZ Yeh, PA Widyastuti, A Van der Walt, J Stankovich, E Havrdova, ... Neurology 96 (24), e2989-e3002, 2021 | 53 | 2021 |
| The Turkish validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) battery S Ozakbas, P Yigit, BP Cinar, H Limoncu, T Kahraman, ... BMC neurology 17, 1-6, 2017 | 51 | 2017 |
| Early clinical markers of aggressive multiple sclerosis CB Malpas, A Manouchehrinia, S Sharmin, I Roos, D Horakova, ... Brain 143 (5), 1400-1413, 2020 | 46 | 2020 |
| Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies S Ozakbas, B Ormeci, E Idiman Journal of the neurological sciences 232 (1-2), 65-69, 2005 | 46 | 2005 |
Turhan KahramanManchester Metropolitan University在 mmu.ac.uk 的电子邮件经过验证
